Researchers have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body. In a new study published today in Nature ...

Tevogen Bio Holdings Inc. has announced its new artificial intelligence initiative, Tevogen.AI™, aimed at enhancing its ExacTcell™ technology for improved target identification and preclinical ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.

Cytokines are small, secreted proteins that transmit messages between cells and members of this superfamily include chemokines, growth factors, interleukins, interferons, colony stimulating factors, ...

REDWOOD CITY, Calif. & SHENZHEN, China--(BUSINESS WIRE)--LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the company’s Series A financing of over $20 ...

As life expectancy increases, 1 in 2 men and 1 in 3 women will develop cancer at least once in their lifetime and die from it. However, over the past 20 years, the pace of anticancer drug development ...

Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...

Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a destructive stress response called TexPSR. Unlike normal stress systems, ...

Glioblastoma remains one of the most lethal primary brain tumors, with limited durable benefit from current standard-of-care approaches. In parallel, ...

Asthma drug montelukast may help improve immunotherapy by stopping tumors from hijacking immune cells, offering hope for ...